The University of Alabama (UAB) Multipurpose Arthritis and Musculoskeletal Diseases Center (MAMDC) is a multidisciplinary program which fosters and promotes research related to the causes, diagnoses, treatments, and improved care of patients with arthritis and musculoskeletal diseases. In order to ensure operational effectiveness, the Administrative Unit of the MAMDC is specifically designed to initiate, promote, and maximize interactions among the Center Director and principal staff; relevant institutional academic and administrative units; staff at the National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); regional, state, and local health agencies and organizations; and individuals and families served by the UAB MAMDC. The Administrative Unit is designed to enable proper governance of the various MAMDC Components through committees and regularly scheduled meetings and seminars serving to enhance communication among the various investigators and administrative staff. To assist the Center Director in his effort to ensure the highest quality in the operation of the UAB MAMDC, five committees with appropriate charges have been established: the Executive Committee; the Research and Development Committee; the Institutional Advisory Committee; the External Advisory Committee; and the Clinical Record System Utilization Committee. The Administrative Unit which has evolved at the UAB MAMDC during the past 14 years has proven to be effective in assisting the Director to ensure that the goals of the MAMDC are fulfilled.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Comprehensive Center (P60)
Project #
5P60AR020614-16
Application #
3108195
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1977-09-20
Project End
1996-12-31
Budget Start
1993-01-25
Budget End
1993-12-31
Support Year
16
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
Schools of Medicine
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wu, Jianming; Xie, Fenglong; Qian, Kun et al. (2011) FAS mRNA editing in Human Systemic Lupus Erythematosus. Hum Mutat 32:1268-77
Wang, Feng; Ezell, Scharri J; Zhang, Yong et al. (2010) FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer. Invest New Drugs 28:234-41
Wang, Wei; Rayburn, Elizabeth R; Velu, Sadanandan E et al. (2009) In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues. Clin Cancer Res 15:3511-8
Wang, Wei; Rayburn, Elizabeth R; Zhao, Yuqing et al. (2009) Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action. Cancer Lett 278:241-248
Wang, Wei; Rayburn, Elizabeth R; Hang, Jie et al. (2009) Anti-lung cancer effects of novel ginsenoside 25-OCH(3)-PPD. Lung Cancer 65:306-11
Wang, Wei; Rayburn, Elizabeth R; Hao, Miao et al. (2008) Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides. Prostate 68:809-19
Annis, Douglas S; Gunderson, Kristin A; Mosher, Deane F (2007) Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations. J Biol Chem 282:27067-75
Rayburn, Elizabeth R; Wang, Wei; Zhang, Ruiwen et al. (2007) Experimental therapy for colon cancer: anti-cancer effects of TLR9 agonism, combination with other therapeutic modalities, and dependence upon p53. Int J Oncol 30:1511-9
Annis, D S; Murphy-Ullrich, J E; Mosher, D F (2006) Function-blocking antithrombospondin-1 monoclonal antibodies. J Thromb Haemost 4:459-68
Rayburn, Elizabeth R; Wang, Wei; Zhang, Zhuo et al. (2006) Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy. Prostate 66:1653-63

Showing the most recent 10 out of 145 publications